96704 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides containing heteroatoms different from O, S, or N
ANTIMICROBIAL PEPTIDES
#2COMPOUNDS CONTAINING DEUTERIUM
#3PEPTIDE
#4THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#5BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#6OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF
#7DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE
#8SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#9BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#10SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#11Deuterated melflufen compounds
#12OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF
#13BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#14SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#15Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
#16Antimicrobial compounds and/or modulators of microbial infections and methods of using the same
#17Therapeutically active compounds and their methods of use
#18BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#19SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#20Therapeutically active compounds and their methods of use
#21Boronate ester compounds and pharmaceutical compositions thereof
#22N-acyldipeptide derivatives and their uses
#23Tripeptide epoxy ketone protease inhibitors
#24BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#25SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#26PRODRUG OF AN ICE INHIBITOR
#27Boronate ester compounds and pharmaceutical compositions thereof
#28SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#29Therapeutically active compounds and their methods of use
#30BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#31CHIRAL SPECIFIC BORON-CONTAINING COMPOUNDS AND THEIR USE IN TREATING CANCER OR AMYLOIDOSIS
#3218F labeled amino acids, derivatives thereof and method of making same
#33Difluoroketamide derivatives as HTRA1 inhibitors
#34Boronate ester compounds and pharmaceutical compositions thereof
#35SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#36BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#37Therapeutically active compounds and their methods of use
#38Delivery systems for controlled drug release
#39Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#40Difluoroketamide derivatives as HtrA1 inhibitors
#41PRODRUG OF AN ICE INHIBITOR
#42Bortezomib conjugates and methods using same
#43Antimicrobial compounds and/or modulators of microbial infections and methods of using the same
#44Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof
#45SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#46BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#47Therapeutically active compositions and their methods of use
#48Synthesis of boronic ester and acid compounds
#49BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#50Tripeptide compound, preparation method therefor, and application thereof
#51Macrocyclic inhibitors of flaviviridae viruses
#52Dipeptides as inhibitors of human immunoproteasomes
#53N-acyldipeptide derivatives and their uses
#54THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#55Ether compounds for treatment of medical disorders
#56Prodrug of an ICE inhibitor
#57Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms
#58Therapeutically active compositions and their methods of use
#59Tripeptide epoxy ketone protease inhibitors
#60Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
#61Synthesis of boronic ester and acid compounds
#62Boronic acid esters and pharmaceutical formulations thereof
#63ALKOXYSILANE DERIVATIVES OF N-ACYL AMINO ACIDS, N-ACYL DIPEPTIDES, AND N-ACYL TRIPEPTIDES, AND PARTICLES AND STABLE OIL-IN-WATER FORMULATIONS USING THE SAME
#644-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#65Process for the preparation of bortezomib mannitol ester
#66Dipeptide and tripeptide epoxy ketone protease inhibitors
#67Antifouling materials
#68Macrocyclic inhibitors of flaviviridae viruses
#69BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#70Prodrug of an ice inhibitor
#71N-acyldipeptide derivatives and their uses
#72Benzylamine derivatives as inhibitors of plasma kallikrein
#73SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#74Alpha-1 antitrypsin variant, preparation method thereof and use thereof
#75Boronate ester compounds and pharmaceutical compositions thereof
#76Boronate ester compounds and pharmaceutical compositions thereof
#774-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#78N-acyldipeptide derivatives and their uses
#79Components for producing amphoteric liposomes
#80Benzylamine derivatives as inhibitors of plasma kallikrein
#81Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#82Method of forming a fiber made of peptide nanostructures
#83Macrocyclic compounds and methods for their production
#84Peptide nanostructures and methods of generating and using the same
#85Boronate ester compounds and pharmaceutical compositions thereof
#86Prodrug of an ice inhibitor
#87Boron containing polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
#88Smart pro-drugs of serine protease inhibitors
#89Therapeutically active compositions and their methods of use
#90Derivatives of glyco-CF-serine and glyco-CF-threonine
#91BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#92SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS
#93SMAC peptidometics useful as IAP inhibitors
#94Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#95Caspase inhibitors
#96Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
#97Compound and methods for its production
#98Process for and intermediates in the preparation of canfosfamide and its salts
#99Substituted propane phosphinic acid derivatives
#100IAP BIR domain binding compounds
#101IAP Inhibitors
#102Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
#103Components for producing amphoteric liposomes
#104Alkoxysilane derivatives of N-acyl amino acids, N-acyl dipeptides, and N-acyl tripeptides, and particles and stable oil-in-water formulations using the same
#105Peptide nanostructures and methods of generating and using the same
#106Diamine Derivatives
#107Peptidic compounds
#108Boronic ester and acid compounds, synthesis and uses
#109DIMERIC IAP ANTAGONISTS
#110Prodrug of an ICE inhibitor
#111ORGANIC COMPOUNDS
#112Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation
#113Inhibitors of serine proteases
#114Diamine Derivatives
#115Macrocyclic peptides as inhibitors of viral replication
#116Urokinase inhibitors, production and use thereof
#117(S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their uses
#118Process for treating the skin comprising applying to the skin at least one composition comprising at least one N-aminoacylamide
#119Pyrrolydine derivatives as IAP inhibitors
#120PROBE COMPOUNDS FOR PROTEIN TYROSINE PHOSPHATASE (PTP) AND PRECURSORS THEREOF
#121BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#122Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
#123COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
#124SUBSTITUTED 1,2-ETHYLENEDIAMINES, METHODS FOR PREPARING THEM AND USES THEREOF
#125Synthesis of boronic ester and acid compounds
#126Smart Pro-Drugs of Serine Protease Inhibitors
#127Lactams and uses thereof
#128Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
#129O-SUBSTITUTED HYDROXYARYL DERIVATIVES
#130Boronic Acid Salts
#131DIMERIC IAP INHIBITORS
#132DIAMINE DERIVATIVES
#133Substituted imidazo[1,2-A]pyrazine derivatives as alpha-helix mimetics and method relating to the treatment of cancer stem cells
#134HYDROXYAMIDINE AND HYDROXYGUANIDINE COMPOUNDS AS UROKINASE INHIBITORS
#135Compounds and compositions as channel activating protease inhibitors
#136CYCLIC MALONAMIDES AS INHIBITORS OF A BETA PROTEIN PRODUCTION
#137Peptide boronic acid inhibitors
#138Multivalent metal salts of boronic acids
#139CYCLIC MALONAMIDES AS INHIBITORS OF ABETA PROTEIN PRODUCTION
#140Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof
#141BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#142HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR
#143Oxadiazole compounds as urokinase inhibitors
#144Macrocyclic inhibitors of hepatitis C virus
#145DIAMINE DERIVATIVES
#146CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
#147Cathepsin Cysteine Protease Inhibitors
#148PEPTIDES AND PEPTIDOMIMETICS HAVING ANTI-PROLIFERATIVE ACTIVITY AND/OR THAT AUGMENT NUCLEIC ACID DAMAGING AGENTS OR TREATMENTS
#149Boronic ester and acid compounds, synthesis and uses
#150IAP BIR domain binding compounds
#151Substituted diketopiperazines as oxytocin antagonists
#152INHIBITORS OF CANCER CELL, T-CELL AND KERATINOCYTE PROLIFERATION
#153Self-assembled Fmoc-ff hydrogels
#154Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
#155METHOD FOR PREPARING LYSOBACTIN DERIVATIVES
#156Hepatitis C inhibitor dipeptide analogs
#157Peptide nanostructures and methods of generating and using the same
#158Anti-cancer compounds
#159Organic compounds
#160Method of forming a fiber made of peptide nanostructures
#1614-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#162Radiolabelling via fluorination of aziridines
#163Prodrug of an ICE inhibitor
#164Antiviral Compounds
#165Peptidic compounds
#166Protease inhibitors for coronaviruses and SARS-CoV and the use thereof
#167Compounds of the N-acylamino amide family compositions comprising them and uses thereof
#168Boronic Acid Salts Useful in Parenteral Formulations
#169Cyclic malonamides as inhibitors of aβ protein production
#170Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
#171Boronic acid salts
#172Hepatitis C Inhibitor Peptide Analogs
#173Water-soluble prodrugs of florfenicol and its analogs
#174COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
#175Macrocyclic Sh2 Domain Binding Inhibitors
#176Boronic ester and acid compounds, synthesis and uses
#177BIS-AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS
#178Lipid lowering biphenylcarboxamides
#179Novel Lactams And Uses Thereof
#180Myd88 Homodimerization Inhibitors
#181Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#182Phosphorus-containing hepatitis C serine protease inhibitors
#183Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof
#184IAP inhibitors
#185Cyclic malonamides as inhibitors of Aβ protein production
#186Dimeric IAP inhibitors
#187DIAMINE DERIVATIVES
#188Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
#189Boronic ester and acid compounds, synthesis and uses
#190Novel affinity labels
#191Substituted piperazines and methods of use
#192VLA-4 antagonists
#193Inhibitors of serine proteases
#194Ptb1b photoprobes
#195Protease inhibitors
#196Pyrrolidine melanocortin-specific compounds
#197Compounds as inhibitors of hepatitis C virus NS3 serine protease
#198Alpha-helix mimetics and method relating to the treatment of cancer stem cells
#199N- or C- terminally modified small peptides
#200Non-racemic trifluoroleucine, and methods of making and using
#201Pyrazole compounds as HSP90 inhibitors for the treatment of cancer
#202Substituted propane phosphinic acid derivatives
#203Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
#204Inhibitors of cancer cell, T-cell and keratinocyte proliferation
#205Method of degrading transcriptional factors of saccharometabolism-associated gene, method for inhibiting the degradation, and agent for inhibiting degradation and degradation inhibitor
#206Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
#207Beta-sheet mimetics and methods relating to the use thereof
#208Cathepsin inhibitors
#209Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX
#210β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
#211Potent and specific immunoproteasome inhibitors
#212Multivalent metal salts of boronic acids
#213Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis
#214Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof
#215Cosmetic compositions comprising N-acylamino amides
#216Compositions comprising oxophosphonate-based metalloproteinase inhibitors
#217Peptide gap junction modulators
#218Compounds and compositions as cathepsin inhibitors
#219Anti-cancer compounds
#220Lactams and uses thereof
#221SH2 domain binding inhibitors
#222Cell adhesion inhibitors
#223Standard compound for immunoassay for dioxin and method of immunoassay for dioxin
#224Pyrrolidin-2-one derivatives as inhibitors of factor xa
#225Pyrrolidin-2-one derivatives as inhibitors of factor xa
#226Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products
#227Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
#228Pyrrolidine derivatives for use in treating heaptitis c virus infection
#229Cyclic malonamides as inhibitors of Aβ protein protection
#230Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
#231Process for and intermediates in the preparation of canfosfamide and its salts
#232Boronic ester and acid compounds, synthesis and uses
#233Antigen delivery platform
#234Antiviral compounds
#235Melanocortin receptor ligands
#236α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors
#237O-substituted hydroxyaryl derivatives
#238Lactams and uses thereof
#239Smart pro-drugs of serine protease inhibitors
#240Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
#241Peptide boronic acid inhibitors
#242Peptide nanostructures and methods of generating and using the same
#243Novel functional peptide nucleic acid and process for producing the same
#244Dipeptide derivatives
#245Hepatitis C inhibitor dipeptide analogs
#246Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
#247Heteroaryl peptidomimetics as thrombin receptor antagonists
#248Bacterial efflux pump inhibitors and methods of treating bacterial infections
#249Boronic acid salts
#250Matrix metalloproteinase inhibitors
#251Diamines as modulators of chemokine receptor activity
#252Formulation of boronic acid compounds
#253Inhibitors of bacterial type III protein secretion systems
#254Diamine derivatives
#255Compounds as inhibitors of hepatitis C virus NS3 serine protease
#256Synthesis of boronic ester and acid compounds
#257Growth hormone secretagogues
#258Piperidine compounds
#2592-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives
#260Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
#261Compositions and methods for inhibiting abnormal cell growth
#262Dipeptide apoptosis inhibitors and the use thereof
#263Process for preparing 1- [N²-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
#264Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof
#265Urokinase inhibitors, production and use thereof
#266Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#267Non-peptidic BRS-3 agonists
#268Components for producing amphoteric liposomes
#269Vitronectin receptor antagonist pharmaceuticals
#270Substituted diketopiperazines as oxytocin antagonists
#271Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
#272Growth hormone secretagogues
#273Compounds and methods for treatment of thrombosis
#274Diamine derivatives
#275Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
#276Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
#277Matrix metalloproteinase inhibitors
#278Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
#279Diamine derivatives
#280Cyclic malonamides as inhibitors of A-β protein production
#281Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient
#282Peptidomimetic inhibitors of STAT activity and uses thereof